Clinical Trials
590
Active:4
Completed:204
Trial Phases
4 Phases
Phase 2:19
Phase 3:31
Phase 4:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (394 trials with phase data)• Click on a phase to view related trials
Not Applicable
335 (85.0%)Phase 3
31 (7.9%)Phase 2
19 (4.8%)phase_2_3
5 (1.3%)Phase 4
4 (1.0%)Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis.
Not Applicable
Not yet recruiting
- Conditions
- Autoimmune Hepatitis
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 40
- Registration Number
- NCT07118657
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India
Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 72
- Registration Number
- NCT07108075
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
To Study Effect of Injection Pentoxifylline on Liver Growth After Major Liver Surgery
Not Applicable
Recruiting
- Conditions
- Liver Regeneration
- Interventions
- Other: Plasmalyte
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 60
- Registration Number
- NCT07085806
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, India
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
Not Applicable
Not yet recruiting
- Conditions
- Acute-On-Chronic Liver Failure
- Interventions
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 100
- Registration Number
- NCT07075315
- Locations
- 🇮🇳
Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
🇮🇳All India Institutes of Medical Sciences (AIIMS), New Delhi, India
🇮🇳Institute of Liver & Biliary Sciences, New Delhi, India
Comparison of the Impact of Different Suspension Mediums on ABO Antibody Titres.
Completed
- Conditions
- Healthy Blood Donor
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 200
- Registration Number
- NCT07054372
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 56
- Next
News
No news found